Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001813704 | SCV002060888 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001869622 | SCV002252468 | benign | RASopathy | 2022-12-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002468320 | SCV002763557 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468319 | SCV002763558 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV003299015 | SCV004002688 | likely benign | Cardiovascular phenotype | 2023-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |